Profile
PRPH TAK ZTS HLN TEVA VTRS
Company Name ProPhase Labs, Inc. Takeda Pharmaceutical Company Limited Zoetis Inc. Haleon plc Teva Pharmaceutical Industries Limited Viatris Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic
Market Cap $711.03K $57.18B $56.15B $49.48B $39.42B $14.94B
Employees 0.10K 49.28K 13.80K 24.56K 37.00K 32.00K
CEO Ted William Karkus Christophe Weber Kristin C. Peck Brian James McNamara Richard D. Francis Scott Andrew Smith
Ratings
PRPH TAK ZTS HLN TEVA VTRS
Quant Rating Score 1 3 3 4 3 2
Quant Rating Strong Sell Neutral Neutral Buy Neutral Sell
Trading
PRPH TAK ZTS HLN TEVA VTRS
Last Close $0.2649 $14.14 $118.8 $9.68 $24.59 $10.66
High 52 $0.83 $15.52 $178.71 $11.41 $25.83 $13.37
Low 52 $0.24 $12.89 $118.8 $8.73 $12.82 $7.26
Price vs. 52 Week High -68.08 % -8.89 % -33.52 % -15.16 % -4.8 % -20.27 %
Price vs. 52 Week Low 10.38 % 9.7 % 0 % 10.88 % 91.81 % 46.83 %
Total Return
PRPH TAK ZTS HLN TEVA VTRS
1 Month Return -47.02 % 0.71 % -17.53 % 2.11 % 27.34 % 4.82 %
3 Month Return -20.69 % -6.73 % -21.96 % -0.05 % 36.16 % 0.28 %
6 Month Return -31.55 % 0.21 % -27.13 % -10.37 % 45.16 % 20.59 %
9 Month Return -39.66 % 1.73 % -24.08 % -3.1 % 48.4 % -1.84 %
YTD Return -65.01 % 6.8 % -27.09 % 1.47 % 11.57 % -14.38 %
1 Year Return -65.14 % 3.82 % -32.33 % 2.11 % 46.28 % -18.31 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
PRPH TAK ZTS HLN TEVA VTRS
Dividend Yield Percentage (TTM) - 3.55 % 1.59 % 1.41 % - 3.7 %
Dividend Paid and Capex Coverage Ration (TTM) -97.82 % 2.23 % 1.89 % 2.01 % 4 % 2.09 %
Dividend Per Share (TTM) - 198 % 2.03 % 0.06 % - 0.48 %
Payout Ratio (TTM) - 277.04 % 32.55 % 27.27 % - -15.34 %
Growth
PRPH TAK ZTS HLN TEVA VTRS
Asset Growth -31.25 % -0.34 % 0.76 % 3.61 % -12.97 %
Gross Profit Growth -100.92 % 9.63 % -0.19 % 10.86 % -12.66 %
Revenue Growth -84.75 % 8.33 % -0.61 % 4.32 % -4.46 %
Revenue 3 Year -93.19 % 24.31 % 19.01 % 11.71 % -16.52 %
Revenue 5 Year -58.45 % 55.65 % 33.95 % -1.27 % -39.86 %
Revenue 10 Year -73.2 % 113.39 % 33.95 % -34.65 % -36.45 %
EBIT Growth -81.09 % 5.67 % 13.52 % -9.52 % -109.43 %
Net Income Growth -217.98 % 6.06 % 37.46 % 185.97 % -1259.41 %
Net Income 3 Yeari Growth Per Share -776.49 % 27.46 % 4.91 % 155.65 % 49.38 %
Net Income 5 Yeari Growth Per Share -928.12 % 74.46 % 122.63 % 133.65 % -1871.56 %
Net Income 10 Yeari Growth Per Share -495.11 % 370.4 % 122.63 % -33.98 % -122.71 %
Operating Income Growth -78.73 % 10.52 % 10.52 % 1131.35 % -98.68 %
Operating Cash Flow Growth (CFG) -54.55 % 25.5 % 9.57 % -35.33 % -17.74 %
Operating 3 Year CFG -2.41 % 39.36 % 71.6 % 0.19 % -22.68 %
Operating 5 Year CFG -1163.97 % 73.18 % 196.04 % 29.24 % -40.08 %
Operating 10 Year CFG -376.42 % 420.39 % 196.04 % -77.86 % -24.47 %
EPS Growth -166.33 % 7.68 % 33.33 % 184.83 % -1262.28 %
EPS Diluted Growth -166.33 % 7.89 % 33.33 % 182.76 % -1269.98 %
Book Value Per Share -86.57 % -2.96 % -1.63 % 36.19 % -8.42 %
Share Holder 3 Year Equity Growth Per Share -90.03 % 9.65 % -37.97 % -2.08 % -7.88 %
Share Holder 5 Year Equity Growth Per Share -60.32 % 85.42 % -40.16 % -24.81 % -26.41 %
Share Holder 10 Year Equity Growth Per Share -40.05 % 301.38 % -40.16 % -80.23 % 90.51 %
Dividend Per Share Growth - 15.33 % 49.01 % - 0.45 %
Dividend 3 Year Growth Per Share -100 % 73.18 % -49.79 % - 45.93 %
Dividend 5 Year Growth Per Share -100 % 163.51 % -49.97 % - -
Dividend 10 Year Growth Per Share - 493.89 % -49.97 % -100 % -
Debt Growth 33.14 % -0.16 % 6.83 % -3.86 % -22.13 %
Free Cash Flow Growth -27.17 % 41.76 % 16.27 % -43.99 % -14.98 %
Updated On 31 Dec 2024 31 Dec 2024 31 Dec 2024 31 Dec 2025 31 Dec 2024
Profitability
PRPH TAK ZTS HLN TEVA VTRS
Gross Profit Margin TTM 191.36 % 59.49 % 70.63 % 61.81 % 51.76 % 36.07 %
Return on Assets TTM -63.47 % 0.73 % 17.49 % 4.78 % 3.48 % -9.73 %
Return on Equity TTM -404.42 % 1.58 % 53.56 % 9.4 % 20.09 % -22.69 %
Return on Capital Employed TTM -258.17 % 3.59 % 26.48 % 8.34 % 11.54 % -8.43 %
Net Income Per EBT TTM 133.11 % 54.99 % 79.59 % 76.52 % 114.62 % 95.92 %
EBT Per Ebit TTM 116.52 % 44.75 % 94.2 % 88.09 % 39.3 % 149.32 %
EBIT Per Revenue TTM -2496.56 % 10.28 % 37.63 % 20.49 % 18.15 % -18.25 %
Cash Flow To Debt Ratio TTM -299.15 % 23.13 % 40.09 % 12.02 % 11.62 % 13.47 %
Receivables Turnover TTM 0.33 5.89 6.1 5.14 4.68 3.94
Payables Turnover TTM -0.02 3.87 6.73 1.18 3.31 6.81
Inventory Turnover TTM -3.7 1.29 1.12 3.72 2.63 2.2
Fixed Asset Turnover TTM 45.85 % 214.23 % 241.44 % 589.57 % 392.13 % 488.38 %
Asset Turnover TTM 1.64 % 28.97 % 61.99 % 34.62 % 42.58 % 37.25 %
Operating Cash Flow Per Share TTM -5.53 710.55 6.58 0.11 1.76 1.7
Free Cash Flow Per Share TTM -5.48 589.53 5.06 0.1 1.32 1.37
Cash Per Share TTM 9.75 % 48236.45 % 470.54 % 7.46 % 309.55 % 99.36 %
Operating Cash Flow Sales Ratio TTM -2134.35 % 25.14 % 31.03 % 9.32 % 11.64 % 14.04 %
Free Cash Flow Operating Cash Flow Ratio TTM 98.98 % 82.97 % 76.82 % 90.65 % 74.99 % 80.65 %
Cash Flow Coverage Ratios TTM -299.15 % 23.13 % 40.09 % 12.02 % 11.62 % 13.47 %
Price To Free Cash Flows Ratio TTM -0.03 9.47 25.07 38.08 26.39 9.34
Price To Operating Cash Flows Ratio TTM -0.03 7.85 19.35 35.1 19.83 7.62
Price Cash Flow Ratio TTM -0.03 7.85 19.35 35.1 19.83 7.62
Income Statement (TTM)
PRPH TAK ZTS HLN TEVA VTRS
Revenue $0.01B $4581.55B $9.26B $11.23B $17.26B $14.74B
Gross Profit $-0B $3001.33B $6.4B $6.95B $8.94B $5.62B
Gross Profit Ratio -2.22% 65.51% 69.1% 61.85% 51.79% 38.15%
EBITDA $-0.03B $1210.51B $3.87B $2.51B $3.14B $2.82B
Net Income $-0.05B $107.93B $2.49B $1.44B $1.41B $-0.63B
EPS Diluted -26.1 33.62 5.47 0.32 1.2 -0.53
Balance Sheet (MRQ)
PRPH TAK ZTS HLN TEVA VTRS
Long Term Debt $0.02B $3966.33B $5.39B $8.62B $15.56B $14.22B
Total Liabilities $0.06B $7312.37B $9.47B $18.09B $32.83B $22.87B
Total Equity $0.01B $6935.98B $4.77B $16.22B $7.91B $18.64B
Total Investments $0B $382.4B $0.03B $0.14B $0B $1.7B
Total Debt $0.02B $4515.27B $6.74B $10.1B $17.38B $14.31B
Total Assets $0.06B $14248.34B $14.24B $34.32B $40.75B $41.5B
Cash Flow Statement (TTM)
PRPH TAK ZTS HLN TEVA VTRS
Net Income $-0.05B $107.93B $2.5B $1.44B $1.42B $-0.63B
Inventory $0B $-34.97B $-0.04B $0.22B $0.15B $-0.72B
Dividends Paid $0B $-302.5B $-0.79B $-0.57B $0B $-0.57B
Operating Cash Flow $-0.02B $1057.18B $2.95B $2.3B $1.65B $2.3B
Capital Expenditure $-0B $-200.8B $-0.66B $-0.25B $-0.5B $-0.33B
Related Stocks
Ticker Name Price
ACB Aurora Cannabis Inc. 3.44
ACOR Acorda Therapeutics, Inc. 0.661
ACRX AcelRx Pharmaceuticals, Inc. 0.86
ADMP Adamis Pharmaceuticals Corporation 0.775
ADMS Adamas Pharmaceuticals, Inc. 8.22
AERI Aerie Pharmaceuticals, Inc. 15.25
AGRX Agile Therapeutics, Inc. 1.51
AKAN Akanda Corp. 0.9438
ALIM Alimera Sciences, Inc. 5.54
ALVO Alvotech 4.86
ALVOW Alvotech 0.4118
AMPH Amphastar Pharmaceuticals, Inc. 28.54
AMRX Amneal Pharmaceuticals, Inc. 14.69
AMYT Amryt Pharma plc 14.7
ANIP ANI Pharmaceuticals, Inc. 76.24
APUS Apimeds Pharmaceuticals US, Inc 1.48
AQST Aquestive Therapeutics, Inc. 3.82
ASRT Assertio Holdings, Inc. 11.91
ATNX Athenex, Inc. 0.2031
AVDL Avadel Pharmaceuticals plc 21.67
ETFs With Exposure to PRPH
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 341.49
ITOT iShares Core S&P Total U.S. Stock Market ETF 0.00022 151.485
VXF Vanguard Extended Market Index Fund 0.00002 218.255
IWC iShares Micro-Cap ETF 0.00145 167.885
DWAS Invesco DWA SmallCap Momentum ETF 0.34 102.15
EES WisdomTree U.S. SmallCap Earnings Fund 0.0001456 60.58
FDM First Trust Dow Jones Select MicroCap Index Fund 0.13 86.7
DWMC AdvisorShares Dorsey Wright Micro-Cap ETF 0.39 30.95
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0 115.08
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 115.06
VBAIX Vanguard Balanced Index Fund Institutional Shares 0 52.59
VBIAX Vanguard Balanced Index Fund Admiral Shares 0 52.59
VBINX Vanguard Balanced Index Fund Investor Shares 0 52.59
AVUV Avantis U.S. Small Cap Value ETF 0.01 115.35
AVUS Avantis U.S. Equity ETF 0 117.495
DFAT Dimensional U.S. Targeted Value ETF 0.00006044 66.77
VTSAX Vanguard Total Stock Market Index Fund 0 166.35
AVSU Avantis Responsible U.S. Equity ETF 0 79.52
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00002 166.39
VITSX Vanguard Total Stock Market Index Fund 0 166.38
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.00013003 16.7
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00002 166.41
DFQTX DFA U.S. Core Equity 2 Portfolio 0 46.28
DCOR Dimensional ETF Trust 0.00000164 76.54
VEMPX Vanguard Extended Market Index InstlPlus 0.00002 410.63
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 312.11
Unlock